Thermo Fisher Scientific ... (TMO)
NYSE: TMO
· Real-Time Price · USD
489.35
4.31 (0.89%)
At close: Aug 15, 2025, 12:37 PM
Thermo Fisher Scientific Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
Cash & Equivalents | 4.58B | 4.13B | 4.01B | 4.64B | 7.08B | 5.51B | 8.08B | 6.15B | 3.13B | 3.48B | 8.52B | 2.92B | 1.89B | 2.75B | 4.48B | 12.03B | 7.02B | 5.58B |
Short-Term Investments | 1.81B | 1.81B | 1.56B | 2B | 1.75B | 1.75B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 374M | 560M | 106M | 492M | 233M | 59M | 94M | 13M | 57M | 155M | 146M | 99M | 50M | 73M | 11M | 74M | 13M |
Other Long-Term Assets | 4.62B | 4.14B | 2.44B | 4.08B | 3.88B | 4.01B | 2.38B | 4.03B | 4.09B | 3.93B | 2.22B | 4.16B | 4.21B | 4.37B | 3B | 2.98B | 2.51B | 2.45B |
Receivables | 10.04B | 9.82B | 9.63B | 9.8B | 9.43B | 9.35B | 9.66B | 9.84B | 9.49B | 9.3B | 9.43B | 8.92B | 8.89B | 8.95B | 8.95B | 6.37B | 6.28B | 6.34B |
Inventory | 5.56B | 5.22B | 4.98B | 5.43B | 5.2B | 5.13B | 5.09B | 5.4B | 5.66B | 5.66B | 5.63B | 5.72B | 5.67B | 5.48B | 5.05B | 4.91B | 4.63B | 4.34B |
Other Current Assets | 2.6B | 2.39B | 1.96B | 1.91B | 2.02B | 1.9B | 1.76B | 1.7B | 1.72B | 1.77B | 1.64B | 1.74B | 1.65B | 1.59B | 1.64B | 1.43B | 1.33B | 1.42B |
Total Current Assets | 24.58B | 23.38B | 22.14B | 23.78B | 25.48B | 23.64B | 24.59B | 23.09B | 20B | 20.21B | 25.23B | 19.3B | 18.1B | 18.78B | 20.11B | 24.72B | 19.26B | 17.68B |
Property-Plant & Equipment | 9.63B | 9.33B | 10.79B | 9.41B | 9.28B | 9.32B | 11B | 9.17B | 9.29B | 9.35B | 10.87B | 8.63B | 8.53B | 8.45B | 9.86B | 7.05B | 6.56B | 6.13B |
Goodwill & Intangibles | 62.4B | 61.82B | 61.39B | 62.99B | 59.36B | 59.89B | 60.69B | 60.67B | 60.71B | 61.11B | 58.67B | 58.3B | 59.64B | 61.1B | 62.07B | 38.84B | 39.29B | 39.65B |
Total Long-Term Assets | 76.65B | 75.66B | 75.18B | 76.58B | 73.02B | 73.45B | 74.14B | 73.97B | 74.11B | 74.45B | 71.92B | 71.24B | 72.48B | 73.97B | 75.01B | 48.88B | 48.44B | 48.25B |
Total Assets | 101.23B | 99.04B | 97.32B | 100.36B | 98.5B | 97.09B | 98.73B | 97.06B | 94.11B | 94.66B | 97.15B | 90.54B | 90.58B | 92.75B | 95.12B | 73.6B | 67.7B | 65.93B |
Account Payables | 2.98B | 3.05B | 3.08B | 2.61B | 2.55B | 2.56B | 2.87B | 2.51B | 2.42B | 2.8B | 3.38B | 2.47B | 2.59B | 2.67B | 2.87B | 2.3B | 2.1B | 2.15B |
Deferred Revenue | 2.81B | 2.87B | 2.85B | 2.66B | 2.59B | 2.63B | 2.69B | 2.55B | 2.59B | 2.66B | 2.6B | 2.57B | 2.72B | 2.87B | 2.65B | 1.44B | 1.47B | 1.4B |
Short-Term Debt | 2.21B | 2.82B | 2.48B | 4.12B | 5.12B | 4.45B | 3.87B | 4.79B | 4.81B | 6.12B | 5.85B | 1.01B | 1.01B | 1.87B | 2.8B | 19M | 4M | 4M |
Other Current Liabilities | 1M | 3.02B | 2.94B | 3.39B | 3.02B | 2.98B | 2.98B | 2.85B | 2.98B | 3B | 3.08B | 3.21B | 2.96B | 3.03B | 2.68B | 2.17B | 1.86B | 2.13B |
Total Current Liabilities | 12.72B | 13.17B | 13.33B | 14.6B | 14.77B | 13.94B | 14.01B | 14.16B | 14.11B | 15.88B | 17.01B | 11.12B | 11B | 12.07B | 13.44B | 7.75B | 6.92B | 7B |
Long-Term Debt | 33.02B | 31.37B | 29.06B | 31.2B | 30.28B | 31.16B | 31.31B | 30.49B | 29.19B | 29.14B | 28.91B | 28.15B | 29.25B | 31.39B | 32.15B | 21.69B | 18.77B | 18.64B |
Other Long-Term Liabilities | 4.27B | 2.84B | 1.61B | 2.92B | 2.94B | 3.14B | 1.9B | 2.98B | 2.94B | 3.06B | 1.75B | 3.2B | 3.3B | 3.37B | 2.1B | 3.16B | 2.73B | 2.59B |
Total Long-Term Liabilities | 37.91B | 36.38B | 34.32B | 36.66B | 36.19B | 37.53B | 37.87B | 37.44B | 36.08B | 36.34B | 36B | 35.69B | 37.11B | 39.55B | 40.71B | 27.14B | 23.92B | 23.88B |
Total Liabilities | 50.63B | 49.55B | 47.65B | 51.27B | 50.96B | 51.47B | 51.88B | 51.59B | 50.19B | 52.23B | 53.01B | 46.81B | 48.11B | 51.62B | 54.15B | 34.89B | 30.84B | 30.87B |
Total Debt | 35.23B | 34.19B | 32.77B | 35.31B | 35.41B | 35.61B | 36.42B | 35.28B | 34.01B | 35.26B | 36.07B | 29.16B | 30.26B | 33.26B | 36.34B | 21.71B | 18.78B | 18.64B |
Common Stock | 444M | 444M | 444M | 444M | 443M | 443M | 442M | 442M | 441M | 441M | 441M | 440M | 440M | 440M | 439M | 439M | 438M | 438M |
Retained Earnings | 55.9B | 54.45B | 53.1B | 51.42B | 49.94B | 48.54B | 47.36B | 45.87B | 44.29B | 43.06B | 41.91B | 40.45B | 39.07B | 37.53B | 35.43B | 33.88B | 32.08B | 30.35B |
Comprehensive Income | -2.8B | -2.34B | -2.7B | -2.48B | -2.41B | -2.76B | -3.22B | -3.03B | -2.92B | -3.05B | -3.1B | -2.93B | -2.72B | -2.34B | -2.33B | -2.65B | -2.63B | -2.56B |
Shareholders Equity | 50.51B | 49.39B | 49.58B | 48.99B | 47.43B | 45.52B | 46.73B | 45.33B | 43.75B | 42.26B | 43.98B | 43.55B | 42.29B | 40.96B | 40.79B | 38.71B | 36.85B | 35.06B |
Total Investments | 1.81B | 2.19B | 2.12B | 2.11B | 2.24B | 1.98B | 59M | 94M | 13M | 57M | 155M | 146M | 99M | 50M | 73M | 11M | 74M | 13M |